Sivan Subburaju, Ph.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glutamate Decarboxylase | 7 | 2017 | 240 | 1.330 |
Why?
|
| Dopamine Agonists | 2 | 2021 | 346 | 1.100 |
Why?
|
| Histone Deacetylase 1 | 2 | 2017 | 132 | 1.030 |
Why?
|
| Apomorphine | 2 | 2021 | 148 | 0.780 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2021 | 471 | 0.650 |
Why?
|
| gamma-Aminobutyric Acid | 8 | 2022 | 1140 | 0.620 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2017 | 20 | 0.580 |
Why?
|
| Hippocampus | 9 | 2022 | 3775 | 0.570 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2017 | 54 | 0.570 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2017 | 2900 | 0.560 |
Why?
|
| Dopamine Antagonists | 1 | 2018 | 278 | 0.550 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 1660 | 0.530 |
Why?
|
| NAD | 1 | 2020 | 619 | 0.530 |
Why?
|
| Schizophrenia | 10 | 2024 | 6972 | 0.500 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 5783 | 0.400 |
Why?
|
| Endothelial Cells | 4 | 2022 | 3584 | 0.380 |
Why?
|
| Vasopressins | 3 | 2008 | 359 | 0.380 |
Why?
|
| Raclopride | 2 | 2021 | 98 | 0.330 |
Why?
|
| Receptors, GABA-A | 3 | 2022 | 624 | 0.300 |
Why?
|
| Bipolar Disorder | 7 | 2018 | 5138 | 0.290 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2007 | 142 | 0.270 |
Why?
|
| Adrenalectomy | 1 | 2007 | 344 | 0.240 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3819 | 0.240 |
Why?
|
| Molecular Chaperones | 3 | 2017 | 762 | 0.220 |
Why?
|
| Corpus Striatum | 2 | 2021 | 1218 | 0.210 |
Why?
|
| Neurons | 6 | 2024 | 9525 | 0.200 |
Why?
|
| Dopamine | 2 | 2021 | 1582 | 0.200 |
Why?
|
| Rats | 10 | 2021 | 23707 | 0.190 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2002 | 61 | 0.190 |
Why?
|
| Prosencephalon | 2 | 2020 | 305 | 0.190 |
Why?
|
| Cell Cycle | 1 | 2009 | 2920 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2017 | 8102 | 0.180 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2021 | 106 | 0.180 |
Why?
|
| Receptors, Vasopressin | 4 | 2008 | 106 | 0.170 |
Why?
|
| Prefrontal Cortex | 2 | 2024 | 2224 | 0.170 |
Why?
|
| Interneurons | 3 | 2020 | 593 | 0.160 |
Why?
|
| Adrenocorticotropic Hormone | 4 | 2008 | 616 | 0.150 |
Why?
|
| Co-Repressor Proteins | 2 | 2016 | 187 | 0.150 |
Why?
|
| Neuroglia | 1 | 2024 | 964 | 0.150 |
Why?
|
| Corticosterone | 3 | 2008 | 301 | 0.150 |
Why?
|
| Animals | 23 | 2022 | 168764 | 0.150 |
Why?
|
| Spermatozoa | 1 | 2002 | 629 | 0.140 |
Why?
|
| Prolactin | 3 | 2009 | 625 | 0.140 |
Why?
|
| Crotalid Venoms | 1 | 1997 | 29 | 0.140 |
Why?
|
| Models, Biological | 3 | 2012 | 9443 | 0.140 |
Why?
|
| Receptors, Glutamate | 1 | 2017 | 227 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 1216 | 0.130 |
Why?
|
| Binding, Competitive | 1 | 2018 | 1140 | 0.130 |
Why?
|
| Hypothalamus | 3 | 2009 | 993 | 0.130 |
Why?
|
| Cytochromes c1 | 1 | 2016 | 8 | 0.130 |
Why?
|
| Pituitary-Adrenal System | 3 | 2008 | 547 | 0.130 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2008 | 697 | 0.120 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 11888 | 0.120 |
Why?
|
| Corticotropin-Releasing Hormone | 4 | 2009 | 361 | 0.120 |
Why?
|
| Oxytocin | 2 | 2009 | 404 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2022 | 14448 | 0.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2022 | 605 | 0.110 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2535 | 0.100 |
Why?
|
| RNA, Messenger | 6 | 2017 | 12768 | 0.090 |
Why?
|
| RNA | 3 | 2017 | 2717 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 858 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2016 | 5020 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2022 | 1964 | 0.090 |
Why?
|
| Gene Expression | 2 | 2016 | 7584 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1130 | 0.080 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 615 | 0.080 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2009 | 132 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 11022 | 0.080 |
Why?
|
| Neural Pathways | 2 | 2017 | 3085 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 1998 | 2770 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 1526 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 1 | 2009 | 165 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2012 | 1216 | 0.070 |
Why?
|
| Corticotrophs | 1 | 2007 | 3 | 0.070 |
Why?
|
| 5' Flanking Region | 1 | 2007 | 31 | 0.070 |
Why?
|
| Synapses | 2 | 2024 | 1754 | 0.070 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 310 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2016 | 18973 | 0.070 |
Why?
|
| Mice | 6 | 2022 | 81819 | 0.060 |
Why?
|
| Cell Line | 2 | 2017 | 15543 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2880 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2018 | 4424 | 0.060 |
Why?
|
| Ephrin-A2 | 1 | 2004 | 25 | 0.060 |
Why?
|
| Growth Cones | 1 | 2004 | 117 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 1240 | 0.050 |
Why?
|
| Eye | 2 | 2004 | 710 | 0.050 |
Why?
|
| Superior Colliculi | 1 | 2004 | 97 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2007 | 820 | 0.050 |
Why?
|
| Mixed Function Oxygenases | 1 | 2004 | 265 | 0.050 |
Why?
|
| Retina | 2 | 2004 | 2657 | 0.050 |
Why?
|
| Neurogenesis | 2 | 2022 | 866 | 0.050 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 9525 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2020 | 6853 | 0.050 |
Why?
|
| Progesterone | 1 | 2007 | 752 | 0.050 |
Why?
|
| Proteins | 1 | 1997 | 5995 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 18071 | 0.050 |
Why?
|
| Transgenes | 2 | 2004 | 1015 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4392 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4562 | 0.050 |
Why?
|
| CpG Islands | 2 | 2018 | 1207 | 0.050 |
Why?
|
| Hypertension | 1 | 2022 | 8626 | 0.050 |
Why?
|
| Anticoagulants | 1 | 1997 | 4862 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 5767 | 0.050 |
Why?
|
| Pregnancy | 2 | 2020 | 30260 | 0.050 |
Why?
|
| Fertilization | 1 | 2002 | 197 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 1445 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3797 | 0.040 |
Why?
|
| Clathrin | 1 | 2022 | 259 | 0.040 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2022 | 142 | 0.040 |
Why?
|
| DNA Repair | 1 | 2009 | 2048 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 2086 | 0.040 |
Why?
|
| Axons | 2 | 2004 | 1682 | 0.040 |
Why?
|
| Visual Pathways | 1 | 2004 | 555 | 0.040 |
Why?
|
| Estradiol | 1 | 2007 | 1947 | 0.040 |
Why?
|
| Elapid Venoms | 1 | 1998 | 39 | 0.040 |
Why?
|
| Stress, Psychological | 3 | 2008 | 4533 | 0.040 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 2009 | 122 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2004 | 1018 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7851 | 0.040 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2017 | 44 | 0.040 |
Why?
|
| Triiodothyronine, Reverse | 1 | 1997 | 22 | 0.040 |
Why?
|
| Male | 12 | 2024 | 363698 | 0.040 |
Why?
|
| Tilapia | 1 | 1997 | 24 | 0.040 |
Why?
|
| Phospholipases A2 | 1 | 1997 | 197 | 0.030 |
Why?
|
| Zebrafish | 3 | 2004 | 3036 | 0.030 |
Why?
|
| Cell Movement | 2 | 2020 | 5194 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1997 | 204 | 0.030 |
Why?
|
| Blood Coagulation Tests | 1 | 1997 | 263 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2016 | 119 | 0.030 |
Why?
|
| Female | 11 | 2024 | 396112 | 0.030 |
Why?
|
| Signal Transduction | 4 | 2018 | 23601 | 0.030 |
Why?
|
| MSX1 Transcription Factor | 1 | 2015 | 53 | 0.030 |
Why?
|
| HIV Infections | 1 | 2022 | 17533 | 0.030 |
Why?
|
| Cyclin D2 | 1 | 2015 | 97 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 1997 | 496 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1997 | 2163 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2009 | 1884 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 7599 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 1997 | 631 | 0.030 |
Why?
|
| RNA Stability | 1 | 2016 | 319 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 59489 | 0.030 |
Why?
|
| Thyroxine | 1 | 1997 | 672 | 0.030 |
Why?
|
| Humans | 15 | 2024 | 765968 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2015 | 6203 | 0.030 |
Why?
|
| Brain | 2 | 2018 | 27171 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3607 | 0.030 |
Why?
|
| Dendrites | 1 | 2015 | 469 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10429 | 0.020 |
Why?
|
| Models, Animal | 1 | 2017 | 2120 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 1886 | 0.020 |
Why?
|
| Cerebellum | 1 | 2018 | 1518 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 1997 | 1180 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2018 | 1714 | 0.020 |
Why?
|
| Supraoptic Nucleus | 1 | 2009 | 28 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2017 | 1865 | 0.020 |
Why?
|
| Genome | 1 | 2018 | 1753 | 0.020 |
Why?
|
| Phenotype | 3 | 2017 | 16721 | 0.020 |
Why?
|
| Microdissection | 1 | 2008 | 152 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2352 | 0.020 |
Why?
|
| Receptors, Corticotropin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Young Adult | 3 | 2024 | 59889 | 0.020 |
Why?
|
| Drinking | 1 | 2008 | 196 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 1087 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2008 | 186 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2007 | 227 | 0.020 |
Why?
|
| Pyrrolidines | 1 | 2008 | 337 | 0.020 |
Why?
|
| Noise | 1 | 2008 | 296 | 0.020 |
Why?
|
| Rodentia | 1 | 2008 | 261 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 612 | 0.020 |
Why?
|
| Aged | 4 | 2024 | 171117 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2741 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2008 | 8278 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 4159 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9550 | 0.010 |
Why?
|
| Cognition | 1 | 2022 | 7049 | 0.010 |
Why?
|
| Middle Aged | 4 | 2024 | 223009 | 0.010 |
Why?
|
| Baculoviridae | 1 | 2004 | 115 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2015 | 22223 | 0.010 |
Why?
|
| Carbocyanines | 1 | 2004 | 177 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2007 | 1689 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 1490 | 0.010 |
Why?
|
| Anesthetics | 1 | 2008 | 525 | 0.010 |
Why?
|
| Eating | 1 | 2008 | 1540 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 3076 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2024 | 41649 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2844 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 17594 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2004 | 907 | 0.010 |
Why?
|
| Indoles | 1 | 2008 | 1839 | 0.010 |
Why?
|
| Adult | 3 | 2024 | 223044 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 2927 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15398 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6069 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4165 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3715 | 0.010 |
Why?
|
| Elapidae | 1 | 1998 | 4 | 0.010 |
Why?
|
| Retinal Ganglion Cells | 1 | 2004 | 810 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 4622 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3273 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2627 | 0.010 |
Why?
|
| Drosophila | 1 | 2004 | 1501 | 0.010 |
Why?
|
| Risk Factors | 1 | 2024 | 74840 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1997 | 860 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 4618 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 12403 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 1892 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1997 | 566 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10729 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2004 | 3449 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2796 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 2968 | 0.010 |
Why?
|
| Organ Transplantation | 1 | 2004 | 1174 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9347 | 0.010 |
Why?
|
| Amino Acids | 1 | 1998 | 1709 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 13024 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 88835 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 13400 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 14652 | 0.000 |
Why?
|
| Mutation | 1 | 2004 | 30198 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 20124 | 0.000 |
Why?
|